Michael Gelband’s Genetron Holdings Limited ADS GTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-18,568
Closed -$95K 2429
2022
Q2
$95K Buy
18,568
+1,731
+10% +$8.88K ﹤0.01% 1746
2022
Q1
$111K Sell
16,837
-32,241
-66% -$353K ﹤0.01% 1994
2021
Q4
$898K Sell
49,078
-4,616
-9% -$153K 0.01% 1133
2021
Q3
$2.23M Buy
53,694
+33,210
+162% +$1.53M 0.03% 685
2021
Q2
$1.24M Sell
20,484
-1,235
-6% -$76.2K 0.01% 899
2021
Q1
$1.4M Buy
21,719
+12,737
+142% +$875K 0.02% 732
2020
Q4
$377K Sell
8,982
-6,859
-43% -$249K ﹤0.01% 1417
2020
Q3
$567K Sell
15,841
-32,780
-67% -$1.26M 0.01% 950
2020
Q2
$1.76M Buy
+48,621
New +$1.97M 0.05% 477

Other funds holding GTH

Michael Gelband's GTH Position: Q3 2022 in Review

Michael Gelband sold out of Genetron Holdings Limited ADS (GTH) in Q3 2022, closing a stake of 18,568 shares — an estimated $95K sold.

Michael Gelband first reported a position in GTH in Q2 2020 and held it in 9 quarters. The position peaked at $2.23M in Q3 2021. 25 funds tracked by Wall St. Rank hold GTH as of Q3 2022.

  • Michael Gelband reported no remaining Genetron Holdings Limited ADS position as of Q3 2022 after selling out during the quarter.
  • Michael Gelband sold 18,568 Genetron Holdings Limited ADS shares in Q3 2022, an estimated $95K.
  • Michael Gelband first reported a position in Genetron Holdings Limited ADS in Q2 2020 and held it in 9 quarters.
  • Michael Gelband's Genetron Holdings Limited ADS position peaked at $2.23M in Q3 2021.
  • 25 funds tracked by Wall St. Rank held Genetron Holdings Limited ADS as of Q3 2022.

Based on ExodusPoint Capital Management's 13F filing for Q3 2022, filed 10 Nov 2022.